+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Glucagon Like Peptide 1 Agonist"

Middle East And Africa Diabetes Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028) - Product Thumbnail Image

Middle East And Africa Diabetes Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)

  • Report
  • August 2023
  • 70 Pages
  • Middle East, Africa
From
Incretin-based Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028) - Product Thumbnail Image

Incretin-based Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)

  • Report
  • April 2023
  • 110 Pages
  • Global
From
Middle-East and Africa Diabetes Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Middle-East and Africa Diabetes Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • October 2022
  • 70 Pages
  • Africa
From
Canada Diabetes Market Report and Forecast 2025-2034 - Product Thumbnail Image

Canada Diabetes Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 250 Pages
  • Canada
From
Type 2 Diabetes Pipeline Analysis Report - Product Thumbnail Image

Type 2 Diabetes Pipeline Analysis Report

  • Report
  • August 2024
  • 150 Pages
  • Global
From
France Diabetes Market Size, Share, Trends and Forecast by Product Type, 2026-2034 - Product Thumbnail Image

France Diabetes Market Size, Share, Trends and Forecast by Product Type, 2026-2034

  • Report
  • March 2026
  • 136 Pages
  • France
From
Post-Bariatric Hypoglycemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Post-Bariatric Hypoglycemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 140 Pages
  • Global
From
Hyperinsulinemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Hyperinsulinemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 128 Pages
  • Global
From
Type 2 Diabetes Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Type 2 Diabetes Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 140 Pages
  • Global
From
Lipodystrophy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Lipodystrophy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 139 Pages
  • Global
From
Prediabetes Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Prediabetes Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 130 Pages
  • Global
From
Diabetic Nephropathy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Diabetic Nephropathy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 134 Pages
  • Global
From
Type 2 Diabetes Market 2025-2029 - Product Thumbnail Image

Type 2 Diabetes Market 2025-2029

  • Report
  • February 2025
  • 221 Pages
  • Global
From
Anti-Diabetic Drug Market - Forecasts from 2025 to 2030 - Product Thumbnail Image

Anti-Diabetic Drug Market - Forecasts from 2025 to 2030

  • Report
  • January 2025
  • 140 Pages
  • Global
From
Asia-Pacific Insulin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type - Product Thumbnail Image

Asia-Pacific Insulin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type

  • Report
  • October 2022
  • 205 Pages
  • Asia Pacific
From
South America Insulin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type - Product Thumbnail Image

South America Insulin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type

  • Report
  • October 2022
  • 177 Pages
From
North America Insulin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type - Product Thumbnail Image

North America Insulin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type

  • Report
  • October 2022
  • 174 Pages
  • North America
From
Middle East & Africa Insulin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type - Product Thumbnail Image

Middle East & Africa Insulin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type

  • Report
  • October 2022
  • 181 Pages
  • Middle East, Africa
From
Glucagon-Like Peptide 1 Agonists Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Thumbnail Image

Glucagon-Like Peptide 1 Agonists Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • January 2024
  • 150 Pages
  • Global
From
Metabolic Syndrome Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application - Product Thumbnail Image

Metabolic Syndrome Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application

  • Report
  • April 2025
  • 90 Pages
  • Global
From
Loading Indicator

The Glucagon Like Peptide 1 Agonist (GLP-1) market is a subset of the larger diabetes drugs market. GLP-1 agonists are a class of drugs used to treat type 2 diabetes, and are designed to mimic the effects of the hormone glucagon-like peptide-1 (GLP-1). GLP-1 agonists work by stimulating the release of insulin, reducing the amount of glucose in the blood, and slowing the rate of gastric emptying. GLP-1 agonists are typically administered via injection, and are used in combination with other diabetes medications. The GLP-1 agonist market is highly competitive, with a number of major pharmaceutical companies offering products. These include Novo Nordisk, Eli Lilly, Sanofi, AstraZeneca, and Boehringer Ingelheim. Show Less Read more